BBIO vs CFG · rev $438.2M vs P/E 15, rev $2.28B
BridgeBio Pharma Inc (BBIO) versus Citizens Financial Group, Inc. (CFG) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Citizens Financial Group, Inc. (CFG) is a banks - regional company listed on US.
Latest reported BBIO revenue for 2026-06-30 was $438.2M. Net income was -$322.4M. BBIO currently screens at market cap $13.24B.
Latest reported CFG revenue for 2026-06-30 was $2.28B. Net income was $587.0M. Revenue was up 5.3% from 2026-03-31 to 2026-06-30. CFG currently screens at market cap $20.67B and trailing P/E 15.1.
BBIO currently screens at market cap $13.24B. CFG currently screens at market cap $20.67B and trailing P/E 15.1.
Not investment advice. Open the BBIO and CFG stock pages for the full models.
Not investment advice.